Genome & Company (KOSDAQ:314130)
South Korea · Delayed Price · Currency is KRW 2,845.00
+135.00 (4.98%)
At close: Oct 10, 2025
Genome & Company Market Cap
Genome & Company has a market cap or net worth of 88.44 billion as of October 10, 2025. Its market cap has decreased by -23.97% in one year.
Market Cap
88.44B
Enterprise Value
82.50B
Revenue
24.02B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,845.00
Market Cap Chart
Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 88.44B, an increase of 23.04%. That is a compound annual growth rate of 3.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 84.24B | -1.13% |
| Dec 30, 2024 | 85.21B | -51.64% |
| Dec 28, 2023 | 176.21B | -28.34% |
| Dec 29, 2022 | 245.90B | -47.55% |
| Dec 30, 2021 | 468.83B | -55.28% |
| Dec 30, 2020 | 1,048.46B | 224.28% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 579.68T |
| SK hynix | 273.06T |
| LG Energy Solution | 93.37T |
| Samsung Biologics | 71.81T |
| Hanwha Aerospace | 56.44T |
| Hyundai Motor Company | 48.05T |
| HD Hyundai Heavy Industries | 46.87T |
| KB Financial Group | 42.53T |